Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
the bone and tissue regeneration. We study musculoskeletal disorders both at the clinical and molecular level in order to understand disease mechanisms. The research group is studying biomarkers of tissue
-
Rosenquist Brandell as project leaders. The research is focused on identifying genetic causes and molecular mechanisms in rare skeletal diseases. The group works closely with the Metabolic Bone Disease group
-
for understanding the mechanisms underlying autoimmune diseases. The applicant should hold a PhD in medicine, immunology, biotechnology, or other relevant area. Experience in cellular and serological immune assays
-
mechanisms of genetic variants, dietary, hormonal regulation, and lipoprotein metabolism are explored in human and preclinical models. Influence of diurnal rhythms, and novel drugs are studied, also in
-
at CMM and SciLifeLab. The overall goal for the lab is to understand fundamental mechanisms of B cell-related immune responses in cancer (and beyond) to identify new avenues for B-cell mediated therapy
-
malformation associated with inherited human vascular diseases. Utilizing mouse models alongside advanced technologies including single-cell RNA sequencing, we aim to decode intricate cellular mechanisms
-
. Despite the knowledge of diseases and their mechanisms, many promising therapeutic approaches are still clinically unavailable. There is no effective way to deliver these therapies to the right organ
-
lineage progression, morphogenesis, and tissue shaping. Mission and assessment criteria We hope to recruit a person with profound experience in experimental developmental biology and solid track record
-
pipeline and disease prognostic factors. Developing, and evaluating, new ground-breaking machine-learning approaches for radiological precision medicine for breast cancer will be the focus for the doctoral